No profile data available.
Oncolytics Biotech Inc. (ONCY) is a healthcare company in the additional cancer treatment drugs industry, based in San Diego, United States, with about 29 full-time employees.
It reported revenue of $0 for fiscal year 2025, and net income of -$28.76 million. Its market capitalization was $73.03 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of oncology treatments. The company develops pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of gastrointestinal (GI) tumors, metastatic colorectal cancer, anal cancer, and metastatic pancreatic cancer.
Oncolytics Biotech reported $0 in revenue for fiscal year 2025.
$73.03 million as of October 9, 2026.
Listed companies of a similar size in the same industry (additional cancer treatment drugs) include Instil Bio, Inc. (TIL), OS Therapies Incorporated (OSTX), Maia Biotechnology, Inc. (MAIA), Xilio Therapeutics, Inc. (XLO).